Phase 2 And 3 Trials Of Sputnik V Happening In India: Russian Vaccine Firm Chief

PUBLISHED ON: November 12, 2020 | Duration: 8 min, 12 sec

facebooktwitteremailkoo
loading..
Kirill Dmitriev, CEO of Russian Direct Investment Fund, the agency spearheading the development and production of coronavirus vaccine Sputnik V in Russia, says initial results have shown an efficacy rate of 92%. "We are sharing results with India's drug regulator. The phase 2 and 3 of the trial are happening in India. We have an agreement that India will use Russia's data," he said.
ALSO WATCH
"A Very Big Source Of Covid Vaccines For World": Bill Gates Praises India

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com